Related Experiment Video
Updated: Aug 16, 2025

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Thallium poisoning: a case report
Oscar Jimenez1, Hector Cáceres2, Luis Gimenez1
1Department of Internal Medicine, Sanatorio de la Providencia, Buenos Aires, Argentina.
Insights
This case highlights accidental thallium poisoning, a rare but severe condition. Early diagnosis and treatment with D-penicillamine are crucial for recovery from thallium toxicity.
Area of Science:
- Toxicology
- Environmental Health
Background:
- Thallium poisoning is an uncommon yet potentially fatal condition, often resulting from accidental exposure.
- Prompt diagnosis and management are essential for patient outcomes.
Observation:
- A 51-year-old woman presented with myalgia, vertigo, asthenia, abdominal pain, jaundice, asterixis, alopecia, facial macules, plantar hyperkeratosis, and lower limb ulcers.
- Initial laboratory tests ruled out common viral hepatitis and autoimmune diseases.
- Elevated urinary thallium levels (540 µg/g) were detected, with other heavy metal tests being normal.
Findings:
- The patient was diagnosed with thallium poisoning.
- Treatment with D-penicillamine (1,000 mg/day) led to a significant improvement in symptoms.
- Annual follow-up confirmed normalization of urinary thallium levels.
Implications:
- This case underscores the importance of considering thallium toxicity in patients with unexplained multi-systemic symptoms.
- Early clinical suspicion and targeted testing can facilitate timely diagnosis and intervention.
- Effective treatment strategies, such as D-penicillamine, can reverse the effects of thallium poisoning.
Abstract:
Thallium poisoning is usually accidental. We present a case of a 51-year-old woman who was evaluated in June 2018 for myalgia, vertigo, asthenia, and abdominal pain. Physical examination revealed temporal-spatial disorientation, jaundice, and asterixis. The laboratory reported the following: bilirubin, 10.3 mg/dL; aspartate transaminase, 78 U/L; alanine transaminase, 194 U/L; albumin, 2.3 g/dL; prothrombin time, 40%; and platelet count, 60,000/mm3. Serology performed for hepatitis A, B, and C; Epstein-Barr virus; cytomegalovirus; and human immunodeficiency virus was negative, and a collagenogram was negative. Physical reevaluation revealed alopecia on the scalp, armpits, and eyebrows; macules on the face; plantar hyperkeratosis; and ulcers on the lower limbs. Tests for lead, arsenic, copper, and mercury were carried out, which were normal; however, elevated urinary thallium (540 µg/g; range, 0.4-10 µg/g) was observed. The patient was treated with ᴅ-penicillamine 1,000 mg/day and recovered her urinary thallium levels were within normal range at annual follow-up. Thallium poisoning is extremely rare and can be fatal in small doses. An adequate clinical approach can facilitate early diagnosis.
Related Concept Videos
Prevention of Further Absorption of Poison
Imaging Studies III: Computed Tomography
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

